<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362879">
  <stage>Registered</stage>
  <submitdate>9/08/2012</submitdate>
  <approvaldate>10/08/2012</approvaldate>
  <actrnumber>ACTRN12612000842864</actrnumber>
  <trial_identification>
    <studytitle>Plasma ropivacaine concentrations after ultrasound-guided transversus abdominis plane block, with and without adrenaline, for gynaecologic surgery</studytitle>
    <scientifictitle>Plasma ropivacaine concentrations after ultrasound-guided transversus abdominis plane block, with and without adrenaline, for gynaecologic surgery</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Plasma ropivacaine concentrations after ultrasound-guided transversus abdominis plane block, with and without adrenaline added.</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Ultrasound-guided transversus abdominis plane block using ropivacine 0.2% (3mg/kg) with adrenaline 1:400,000 added, for postoperative analgesia after gynaecologic surgery</interventions>
    <comparator>Ultrasound-guided transversus abdominis plane block using ropivacine 0.2% (3mg/kg) without any adrenaline added, for postoperative analgesia after gynaecologic surgery</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Plasma ropivacaine concentration</outcome>
      <timepoint>10, 20, 30, 40, 50, 60, 90, 120, 150, 180 minutes after completion of the block injections.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Female patients more than 18 years of age undergoing elective gynaecological surgery and who are planned to receive transversus abdominis plane blocks will be included.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients will be excluded if they have any allergy/sensitivity to local anaesthetic, infection at the site of block placement, pre-existing neurologic or muscular disease, bleeding tendency or evidence of coagulopathy, significant renal or liver dysfunction, or are pregnant.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/09/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>A/Prof John Loadsman</primarysponsorname>
    <primarysponsoraddress>Anaesthetics
Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW
2050</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Prince Alfred Hospital</fundingname>
      <fundingaddress>Missenden Rd
Camperdown NSW
2050</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will investigate the effect of including a small amount of adrenaline in the local anaesthetic (ropivacaine) solution used for the abdominal wall nerve blocks commonly performed now to provide pain relief after abdominal surgery.  Ropivacaine is commonly used for these nerve blocks because it is a longer-acting local anaesthetic. Adrenaline is a naturally occurring substance in the human body. It is commonly added to local anaesthetics to increase the duration of their effect, and to reduce the rate local anaesthetic is taken up into the blood stream (to limit the risk of side effects to the local anaesthetic). The specific purpose of this study is to determine how much, if at all, the inclusion of adrenaline reduces uptake of the local anaesthetic ropivacaine, with these particular blocks, and thus whether or not it increases the safety. Currently, adrenaline is routinely added to local anaesthesics for certain types of nerve blocks but its potential safety benefit in abdominal wall blocks using ropivacaine is unclear.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethics Review Committee, Royal Prince Alfred Hospital</ethicname>
      <ethicaddress>Research Development Office
Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050</ethicaddress>
      <ethicapprovaldate>5/07/2012</ethicapprovaldate>
      <hrec>X12-0115 &amp; HREC/12/RPAH/197</hrec>
      <ethicsubmitdate>10/04/2012</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Associate Professor John Loadsman</name>
      <address>Dept of Anaesthetics
Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050</address>
      <phone>+61 2 95156111</phone>
      <fax>+61 2 95192455</fax>
      <email>http://anaes.med.usyd.edu.au/mail/messagejl.html</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Associate Professor John Loadsman</name>
      <address>Dept of Anaesthetics
Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050</address>
      <phone>+61 2 95156111</phone>
      <fax>+61 2 95192455</fax>
      <email>http://anaes.med.usyd.edu.au/mail/messagejl.html</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>